Hong Kong Pharmaceuticals & Biotech Most Popular Stocks

Hansoh Pharmaceutical Group

Market Cap: HK$181.8b

An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.

Innovent Biologics

Market Cap: HK$132.9b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$128.5b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$96.8b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, metabolism, and other therapeutic areas in the People’s Republic of China and internationally.

Akeso

Market Cap: HK$84.7b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.

Sino Biopharmaceutical

Market Cap: HK$83.8b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

CSPC Pharmaceutical Group

Market Cap: HK$82.8b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

RemeGen

Market Cap: HK$62.1b

A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.

WuXi XDC Cayman

Market Cap: HK$60.5b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

3SBio

Market Cap: HK$41.4b

An investment holding company, engages in the development, production, marketing, and sale of biopharmaceutical products in the People’s Republic of China, the United States, and internationally.

Biocytogen Pharmaceuticals (Beijing)

Market Cap: HK$38.9b

A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.

Shanghai Henlius Biotech

Market Cap: HK$34.0b

Engages in the research and development of biologic medicines with a focus on oncology, autoimmune diseases, and ophthalmic diseases.

Shanghai Junshi Biosciences

Market Cap: HK$31.7b

A biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.

China Resources Pharmaceutical Group

Market Cap: HK$30.4b

An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.

XtalPi Holdings

Market Cap: HK$30.3b

Operates as a research platform company in Mainland China, the United States, and internationally.

Genscript Biotech

Market Cap: HK$28.5b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

China Medical System Holdings

Market Cap: HK$26.6b

An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.

Simcere Pharmaceutical Group

Market Cap: HK$25.9b

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.

InnoCare Pharma

Market Cap: HK$23.1b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Sunshine Lake Pharma

Market Cap: HK$20.0b

Engages in the research, development, manufacture, and sale of pharmaceutical products for the treatment of infectious diseases, chronic diseases, and oncology.

InSilico Medicine Cayman TopCo

Market Cap: HK$19.4b

Engages in applying artificial intelligence (AI) solutions to drug discovery and development by leveraging its proprietary platforms.

Grand Pharmaceutical Group

Market Cap: HK$17.7b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

United Laboratories International Holdings

Market Cap: HK$17.3b

An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.

Keymed Biosciences

Market Cap: HK$17.3b

A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China, the United States, and the United Kingdom.

Duality Biotherapeutics

Market Cap: HK$16.8b

A clinical-stage biopharmaceutical company, discovers and develops antibody-drug conjugate (ADC) therapeutics to treat cancer, autoimmune diseases, and others.

Metis TechBio

Market Cap: HK$15.2b

Engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States.

Fujian Haixi Pharmaceuticals

Market Cap: HK$13.9b

Engages in research and development, production, and sale of pharmaceutical products in China.

TenNor Therapeutics (Suzhou)

Market Cap: HK$13.6b

Engages in discovery, development and commercialization of differentiated therapies for diseases associated with bacterial infections and bacterial metabolism.

TransThera Sciences (Nanjing)

Market Cap: HK$13.1b

TransThera Sciences (Nanjing), Inc., clinical stage pharmaceutical company company, discovers, develops, and commercializes small molecule therapies for oncology, inflammatory, and cardiometabolic diseases.

Ascentage Pharma Group International

Market Cap: HK$12.8b

A clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China.

Consun Pharmaceutical Group

Market Cap: HK$11.6b

Produces and sells pharmaceutical products in Mainland China.

Ab&B Bio-Tech JS

Market Cap: HK$11.5b

Ab&B Bio-Tech CO., LTD. JS researchs, develops, manufactures, and sells vaccines and biological preparations that provide active immunity against diseases.

Nanjing Leads Biolabs

Market Cap: HK$10.7b

A clinical-stage biotechnology company, engages in the research, development, and commercialization of novel antibody drugs worldwide.

LongBio Pharma (Suzhou)

Market Cap: HK$10.7b

Engages in discovery and development of biopharmaceuticals that targets allergic and autoimmune diseases in the People's Republic of China and Hong Kong.

Ascletis Pharma

Market Cap: HK$10.6b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

GenFleet Therapeutics (Shanghai)

Market Cap: HK$10.4b

A biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States.